| TNF-alpha in promotion and progression of cancer | Cancer and Metastasis Reviews | 2006 | 573 |
| Tumour necrosis factor-alpha as a tumour promoter | European Journal of Cancer | 2006 | 410 |
| Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells | Blood | 2006 | 331 |
| Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib | Cancer Research | 2006 | 315 |
| Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype | Journal of Immunology | 2006 | 308 |
| Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines | Proceedings of the National Academy of Sciences of the United States of America | 2006 | 279 |
| Gene therapy: therapeutic gene causing lymphoma | Nature | 2006 | 219 |
| New functions of XPC in the protection of human skin cells from oxidative damage | EMBO Journal | 2006 | 204 |
| In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion | Clinical Cancer Research | 2006 | 132 |
| Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models | Cancer Research | 2006 | 125 |
| Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium | Molecular Cancer Therapeutics | 2006 | 102 |
| MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer | Oncogene | 2006 | 81 |
| Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin | Clinical Cancer Research | 2006 | 80 |
| Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia | International Immunology | 2006 | 79 |
| The chemokine network: a target in cancer biology? | Advanced Drug Delivery Reviews | 2006 | 59 |
| MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma | Gynecologic Oncology | 2006 | 55 |
| Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer | Journal of Clinical Oncology | 2006 | 53 |
| Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1 | Cancer Research | 2006 | 52 |
| A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene | Cancer Research | 2006 | 50 |
| Identification and immunotherapeutic targeting of antigens induced by chemotherapy | Nature Biotechnology | 2006 | 49 |
| Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin | Cancer Research | 2006 | 47 |
| Characterization of apoptosis induced by marine natural products in non small cell lung cancer A549 cells | Cellular and Molecular Life Sciences | 2006 | 41 |
| Long term responses with cetuximab therapy in glioblastoma multiforme | Cancer Biology and Therapy | 2006 | 41 |
| Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus | BMC Cancer | 2006 | 32 |
| Molecular biology of malignant gliomas | Clinical and Translational Oncology | 2006 | 26 |
